PubMed:19759529 / 1808-2080 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T11 0-272 Sentence denotes Together these findings show that the GlyT1 inhibitor, SSR103800, produces antipsychotic-like effects, which differ from those observed with compounds primarily targeting the dopaminergic system, and has a reduced side-effect potential as compared with these latter drugs.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
6490 38-43 GeneOrGeneProduct denotes GlyT1 NCBIGene:14664
6491 55-64 ChemicalEntity denotes SSR103800 -1
6492 175-187 ChemicalEntity denotes dopaminergic MESH:D004298

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T46 15-23 GeneOrGeneProduct denotes findings
T47 38-43 GeneOrGeneProduct denotes GlyT1
T48 44-53 GeneOrGeneProduct denotes inhibitor
T49 89-93 GeneOrGeneProduct denotes like
T50 200-205 GeneOrGeneProduct denotes has a
T51 206-213 GeneOrGeneProduct denotes reduced
T52 214-218 GeneOrGeneProduct denotes side

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T25 38-43 GeneOrGeneProduct denotes GlyT1
T26 44-53 GeneOrGeneProduct denotes inhibitor
T27 89-93 GeneOrGeneProduct denotes like
T28 206-213 GeneOrGeneProduct denotes reduced
T29 214-218 GeneOrGeneProduct denotes side

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T13 38-43 GeneOrGeneProduct denotes GlyT1

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T57 55-64 ChemicalEntity denotes SSR103800 ChemicalEntity
T58 175-187 ChemicalEntity denotes dopaminergic ChemicalEntity

LitCoin-training-merged

Id Subject Object Predicate Lexical cue ID:
T58 175-187 ChemicalEntity denotes dopaminergic ChemicalEntity
T57 55-64 ChemicalEntity denotes SSR103800 ChemicalEntity
T21495 38-43 GeneOrGeneProduct denotes GlyT1